Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental models of multiple sclerosis.

H Lassmann1

  • 1Centre for Brain Research, Medical University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria. hans.lassmann@meduniwien.ac.at

Revue Neurologique
|July 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study.

Frontiers in neurology·2022
Same author

PDE10A antibodies in autoimmune encephalitis: A possible marker of cancer immunotherapy?

Neurology·2019
Same author

Pro-inflammatory activation of microglia in the brain of patients with sepsis.

Neuropathology and applied neurobiology·2018
Same author

CNS neuroimmunology seen by a neuropathologist.

Revue neurologique·2014
Same author

TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014
Same author

Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2012
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Multiple sclerosis (MS) research uses experimental autoimmune encephalomyelitis (EAE) models, but these models only partially mimic MS complexity. Careful selection of EAE models is crucial for studying MS pathogenesis and therapy development.

Area of Science:

  • Neuroimmunology
  • Central Nervous System (CNS) Disorders

Background:

  • Multiple sclerosis (MS) is an autoimmune disease characterized by inflammatory demyelination in the CNS.
  • MS pathology is complex and heterogeneous, with lesions similar to those in MS inducible in animal models.
  • Experimental autoimmune encephalomyelitis (EAE) is a common animal model for studying MS pathogenesis and therapeutic strategies.

Purpose of the Study:

  • To evaluate the utility of EAE models in understanding MS pathology.
  • To assess the limitations of EAE models for testing novel MS therapies.
  • To emphasize the importance of selecting appropriate EAE models for specific research questions.

Main Methods:

  • Induction of EAE in experimental animals via auto-immunization with brain antigens.

Related Experiment Videos

  • Analysis of pathological features and disease progression in EAE models.
  • Comparison of EAE model characteristics with the spectrum of MS pathology.

    • Main Results:

    • EAE models replicate certain aspects of MS pathology, particularly inflammatory demyelination.
    • No single EAE model fully encompasses the heterogeneity and complexity of MS.
    • EAE models demonstrate limitations in fully reflecting the entire pathological spectrum of MS.

    Conclusions:

    • EAE is a valuable tool for investigating specific mechanisms of MS pathogenesis.
    • The broad spectrum of EAE models offers insights into distinct facets of MS.
    • The effectiveness of EAE models for MS therapeutic testing is constrained, necessitating judicious model selection.